BOT 1.18% 42.0¢ botanix pharmaceuticals ltd

Ann: Investor Presentation and Investor Meetings, page-58

  1. 7,651 Posts.
    lightbulb Created with Sketch. 618
    he is also not paid big money to check the spelling mistakes of this management on the investor presentation and to make it worse the snip it of the instruction leaflet, which happens to be the only cause of the FDA rejection.

    He has every right as share holder of this company to criticize the hopeless management for continuously making such critical errors.

    your point as absurd as saying " general population is not qualified to critique the government because the average joe doesn't know how to run the government"

    enough of ramping and protecting these koalas.

    no wonder the share price of this company is stuck in the mud for the last 6 years if not more!
    Last edited by Zeeshan: 05/11/23
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
42.0¢
Change
-0.005(1.18%)
Mkt cap ! $752.8M
Open High Low Value Volume
43.0¢ 43.3¢ 41.5¢ $1.961M 4.631M

Buyers (Bids)

No. Vol. Price($)
34 484194 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 136432 12
View Market Depth
Last trade - 15.53pm 12/09/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.